Certified by Founder
Lodge
Eligo Bioscience
start up
France
- Paris, Il de France
- 06/12/2023
- Series B
- $30,000,000
Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing.
- Industry Biotechnology Research
- Website https://eligo.bio/
- LinkedIn https://www.linkedin.com/company/eligo-bioscience/about/
Related People
Xavier DuportetCo Founder
France -
Paris, Île-de-France
I am an engineer and a geneticist, turned entrepreneur.
Canopy(1) | $22,000,000 | (Jan 13, 2026)
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
MEDIPOST, Inc. | $140,000,000 | (Jan 13, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)
Kinaset Therapeutics | $103,000,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
VelaFi | $20,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
Avenue Biosciences | $7,500,000 | (Jan 13, 2026)
Unusual | $3,600,000 | (Jan 13, 2026)